🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Investigational Drug Gaining Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Followers are urged to message these accounts directly for source information, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where communities with numerous of members share comparison photos, administration instructions and claims of rapid British shipping. Vendors market the substance there before directing customers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, doctors and chemists have warned that the sale of what is still an unlicensed medication in the United Kingdom is worrisome and could lead to individuals injecting products of uncertain source.

Several professionals stated the popularity for retatrutide could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the British medical regulations.

Some content creators try to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach pharmaceutical, advertising, and customer laws, risking fines, legal action or prison.

Service Response and Material Elimination

According to the social media company, the service has removed violative material and prohibited associated hashtags and search suggestions. The organization stated it was committed to keeping the service safe and allocating resources in enhancing enforcement strategies.

Digital Marketplace Operations

Research also discovered communities with up to nine thousand participants marketing the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately brings up channels with numerous of users, filled with photos of weight loss, glowing testimonials and step-by-step guides for preparing or injecting at residence.

After minutes of joining one community, a vendor posted contact information, where most purchases take place. The seller sent an instruction manual and guaranteed shipping within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None asked about weight, medical conditions or previous experience.

Product Information and Costs

Within these groups, messages display black plastic packages with Royal Mail stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with sterile water, or pre-filled pens usually sold at 160 pounds for 20 milligrams. When asked how much time a pen should last, vendors give conflicting answers ranging from a several days to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for the messaging service stated it actively monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting materials they can’t verify. Even if the science behind retatrutide is valid, these online products may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent price rises for approved slimming medications such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.

Her team has previously seen individuals injured by personal administration from unverified sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can market [it] for human use,” they said, noting that any product “falsely representing itself as a Lilly investigational product not yet approved … may subject patients to possibly serious health risks”.